Operational for more than 40 years, DiaSorin is a private company that develops and manufactures reagents for in vitro diagnostics. It offers products for infectious diseases, hepatitis, endocrinology, bone and mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The company provides a range of automated hepatitis assays for the diagnosis of viral hepatitis A and B. The company provides a variety of products for the management of bone- and calcium-related diseases. DiaSorin develops, produces and distributes immunoreagent kits for clinical diagnostics. It specializes in developing, producing and distributing immunodiagnostics products. Diasorin maintains more than 80 independent distributors in over 60 countries worldwide. It operates 15 companies in Europe, Asia and North America.